← Open Payments lookup

MARY LEE: Open Payments

NPI 1194277244 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,457 in 28 payments from 9 companies in 2025. Trend: 2023 $2,556 · 2024 $2,616 · 2025 $1,457

Consulting: $740Food & beverage: $717
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$876
Alkermes, Inc.6$239
Teva Pharmaceuticals USA, Inc.4$93
Lundbeck LLC5$81
Neurocrine BioSciences, Inc.3$59
Vanda Pharmaceuticals Inc.2$44
Otsuka America Pharmaceutical, Inc.2$32
Abbott Laboratories1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: COBENFY, LYBALVI, ARISTADA, REXULTI, INGREZZA, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across AL — which companies pay providers there.